Steven Zeicher believes that antibodies against spike protein can have enzymatic activity somewhat like ACE2.
Weaknesses of this theory include:
- Doesn’t explain both positive and negative responses to reinfection, COVID vaccination, antibody-removing treatments like plasmapheresis, or the addition of antibodies via IVIG.
- Doesn’t explain wide variety of symptoms.